Acadia Pharmaceuticals (ACAD) PT Lowered to $35 at JMP Securities
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $28.38 -3.63%
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
JMP Securities analyst Jason Butler lowered the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $35.00 (from $42.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Canaccord Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)
- Cellebrite (CLBT) PT Lowered to $15 at TD Cowen
- JPMorgan Downgrades Denso Corp. (6902:JP) (DNZOY) to Underweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
